Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Merkel

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphomaOlaf Merkel, Frank Hamacher, Daniela Laimer, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 30, 2011
Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic targetKarin Jöhrer, Marlene Obkircher, Daniel Neureiter, et al.
Redox Biology|March 12, 2025
Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the CentrosomeCatello Giordano, Jonatan Kendler, Maximilian Sexl, et al.
Cancers|January 11, 2022
BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCLGavin D Garland, Stephen P Ducray, Leila Jahangiri, et al.
Cell Reports|October 6, 2016
Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation ProfilingMelanie R Hassler, Walter Pulverer, Ranjani Lakshminarasimhan, et al.
British Journal of Haematology|June 26, 2023
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinibNina Prokoph, Jamie D Matthews, Ricky M Trigg, et al.
Cell Reports. Medicine|March 20, 2024
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphomaNicole Prutsch, Shuning He, Alla Berezovskaya, et al.
Cancers|October 13, 2021
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)Kathrin D Wurster, Mariantonia Costanza, Stephan Kreher, et al.
Leukemia & Lymphoma|April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemiaG Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.
British Journal of Haematology|July 1, 2014
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approachG Doreen Te Raa, Jitka Malčiková, Marek Mraz, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphomaOlaf Merkel, Frank Hamacher, Daniela Laimer, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 30, 2011
Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic targetKarin Jöhrer, Marlene Obkircher, Daniel Neureiter, et al.
Redox Biology|March 12, 2025
Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the CentrosomeCatello Giordano, Jonatan Kendler, Maximilian Sexl, et al.
Cancers|January 11, 2022
BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCLGavin D Garland, Stephen P Ducray, Leila Jahangiri, et al.
Cell Reports|October 6, 2016
Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation ProfilingMelanie R Hassler, Walter Pulverer, Ranjani Lakshminarasimhan, et al.
British Journal of Haematology|June 26, 2023
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinibNina Prokoph, Jamie D Matthews, Ricky M Trigg, et al.
Cell Reports. Medicine|March 20, 2024
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphomaNicole Prutsch, Shuning He, Alla Berezovskaya, et al.
Cancers|October 13, 2021
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)Kathrin D Wurster, Mariantonia Costanza, Stephan Kreher, et al.
Leukemia & Lymphoma|April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemiaG Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.
British Journal of Haematology|July 1, 2014
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approachG Doreen Te Raa, Jitka Malčiková, Marek Mraz, et al.
Pageof 6